R
Ringpai National Chain Veterinary Hospital
Tianjin Based is a Healthcare Start Up based in Tianjin
About Ringpai National Chain Veterinary Hospital
Ringpai National Chain Veterinary Hospital operates as a large-scale provider of pet healthcare services in China, functioning through a model of operating and managing a wide network of pet hospitals. The company was established on December 27, 2012, by Dr. Li Shunjun, who is also the founder of the A-share listed veterinary drug company, Ruipu Bio. Dr. Li, the chairman of Ringpai, has an extensive background in the veterinary and technology sectors and has been recognized with honors such as "Tianjin Outstanding Entrepreneur" and awards for his contributions to the livestock and veterinary industry.
Ringpai's business is centered on providing comprehensive veterinary medical services. Its revenue streams are derived from these medical services, which include specialized departments like soft tissue surgery, oncology, and ultrasound, as well as the sale of pet food, pet products, and grooming services. The company primarily serves pet owners across China, operating in the rapidly expanding Chinese pet market. The company has pursued a growth strategy that involves both the acquisition and merger of existing hospitals and the construction of new facilities. This strategy is based on a partnership model where the original founders of acquired hospitals retain a stake and continue to manage operations, while Ringpai provides support in areas like supply chain management, human resources, and marketing to improve profitability.
The company's network has grown significantly, now encompassing over 600 hospitals and clinics across more than 70 cities in 27 provinces, handling over 3 million cases annually. The facilities are equipped with advanced medical technology, including CT scanners, MRI machines, digital radiography, and equipment for specialized treatments like hemodialysis. Ringpai has secured substantial investment from a roster of domestic and international firms, including Goldman Sachs, Mars, Inc., and Mengniu Dairy. In a move towards global expansion, Ringpai entered into a strategic cooperation with Pets Central in Hong Kong in March 2024 to enhance its service offerings and international presence.
Source: Dealroom company dataAt a glance
- Outcome tier
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
News
Open roles
Ringpai National Chain Veterinary Hospital in the Dongli District ecosystem
The Ringpai National Chain Veterinary Hospital office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- YFYuexiu Industrial Fund
Series B and later1 investor entered at this stage
China Mengniu Dairy
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
6 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ringpai National Chain Veterinary Hospital on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ringpai National Chain Veterinary Hospital on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

